Synergistic application of Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopic Imaging (MRSI) for accurate tumor delineation in radiation therapy treatment planning of glioblastomas
Synergistic application of Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopic Imaging (MRSI) for accurate tumor delineation in radiation therapy treatment planning of glioblastomas
正电子发射断层扫描 (PET) 和磁共振波谱成像 (MRSI) 的协同应用在胶质母细胞瘤放射治疗计划中准确描绘肿瘤
批准号：
440379
负责人：
Nosrati Reyhaneh
金额：
$7.29万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2022-12-01
中文摘要
翻译
胶质母细胞瘤是最具侵袭性和致命性的脑癌，占所有脑肿瘤的50%。尽管广泛的研究旨在改善GBM的治疗，但治疗效果仍然非常差，目前的5年存活率仅为
英文摘要
Glioblastoma is the most aggressive and lethal type of brain cancer accounting for 50% of all brain tumors. Despite extensive research aiming to improve GBM treatment, treatment efficacy is still extremely poor and the current 5-year survival rate is only
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synergistic application of Positron Emission Tomography (PET) and high-resolution Magnetic Resonance Spectroscopic Imaging (MRSI) for accurate tumor delineation in radiation therapy treatment planning of glioblastomas
-
批准号：436180
-
项目类别：Fellowship Programs
-
资助金额：$10.2万
-
财政年份：2020
-
负责人：Nosrati Reyhaneh
-
依托单位：
海外基金
